Debasis Patnaik

Also affiliated with Massachusetts General Hospital, Precision Therapeutics (United States)

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes”.

A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2217864120

N/A

0.617DataRank · unranked

60 citations

Jinsoo Seo, Audrey Lee, Oleg Kritskiy, Debasis Patnaik, Jay Penney +13 more

Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) Protein

ACS Chemical Neuroscience(2020)10.1021/acschemneuro.0c00380

N/A

0DataRank · unranked

8 citations

Debasis Patnaik, Steve Gagné, Joshua A. Bishop, Sean Lipsit, S. Amat +8 more

Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins

Nuclear Medicine and Biology(2020)10.1016/j.nucmedbio.2020.04.003

N/A

0DataRank · unranked

8 citations

Xiaoxia Lü, Yu Lan, Zude Chen, Debasis Patnaik, Stephanie A. Fiedler +4 more

Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) Protein

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.18.159665

N/A

0DataRank · unranked

1 citations

Debasis Patnaik, Steve Gagné, Josh Bishop, Sean Lipsit, S. Amat +8 more

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Scientific Reports(2024)10.1038/s41598-024-59110-7

N/A

0DataRank · unranked

11 citations

Daniel M. Fass, N. Connor Payne, Angela She, Debasis Patnaik, Krista M. Hennig +13 more